» Articles » PMID: 28947098

Cost Evaluation to Optimise Radiation Therapy Implementation in Different Income Settings: A Time-driven Activity-based Analysis

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2017 Sep 27
PMID 28947098
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: With increasing recognition of growing cancer incidence globally, efficient means of expanding radiotherapy capacity is imperative, and understanding the factors impacting human and financial needs is valuable.

Materials And Methods: A time-driven activity-based costing analysis was performed, using a base case of 2-machine departments, with defined cost inputs and operating parameters. Four income groups were analysed, ranging from low to high income. Scenario analyses included department size, operating hours, fractionation, treatment complexity, efficiency, and centralised versus decentralised care.

Results: The base case cost/course is US$5,368 in HICs, US$2,028 in LICs; the annual operating cost is US$4,595,000 and US$1,736,000, respectively. Economies of scale show cost/course decreasing with increasing department size, mainly related to the equipment cost and most prominent up to 3 linacs. The cost in HICs is two or three times as high as in U-MICs or LICs, respectively. Decreasing operating hours below 8h/day has a dramatic impact on the cost/course. IMRT increases the cost/course by 22%. Centralising preparatory activities has a moderate impact on the costs.

Conclusions: The results indicate trends that are useful for optimising local and regional circumstances. This methodology can provide input into a uniform and accepted approach to evaluating the cost of radiotherapy.

Citing Articles

Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in Spain.

Corral J, Algara M, Munoz-Montplet C, Eraso A, Giralt J, Defourny N Front Public Health. 2025; 12:1474376.

PMID: 39749236 PMC: 11694224. DOI: 10.3389/fpubh.2024.1474376.


Determining the Relationship between Delivery Parameters and Ablation Distribution for Novel Gel Ethanol Percutaneous Therapy in Ex Vivo Swine Liver.

Chelales E, von Windheim K, Banipal A, Siebeneck E, Benham C, Nief C Polymers (Basel). 2024; 16(7).

PMID: 38611255 PMC: 11013462. DOI: 10.3390/polym16070997.


Automatic end-to-end VMAT treatment planning for rectal cancers.

Huang K, Chung C, Ludmir E, Zhang L, Owens C, Vega J J Appl Clin Med Phys. 2024; 25(4):e14259.

PMID: 38317597 PMC: 11005975. DOI: 10.1002/acm2.14259.


ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocol.

Aggarwal A, Court L, Hoskin P, Jacques I, Kroiss M, Laskar S BMJ Open. 2023; 13(12):e077253.

PMID: 38149419 PMC: 10711912. DOI: 10.1136/bmjopen-2023-077253.


Linear accelerator maintenance cost analysis.

Carlone M, Beckham W, Duzenli C, Kohli K, Tyldesley S J Appl Clin Med Phys. 2023; 25(2):e14246.

PMID: 38134322 PMC: 10860406. DOI: 10.1002/acm2.14246.